These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15862659)

  • 1. Validation in pharmaceutical analysis. Part II: Central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data.
    Ermer J; Ploss HJ
    J Pharm Biomed Anal; 2005 Apr; 37(5):859-70. PubMed ID: 15862659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Setting acceptance criteria for validation of analytical methods of drug eluting stents: Minimum requirements for analytical variability.
    Kamberi M; Garcia H; Feder DP; Rapoza RJ
    Eur J Pharm Sci; 2011 Feb; 42(3):230-7. PubMed ID: 21126583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.
    Hubert P; Nguyen-Huu JJ; Boulanger B; Chapuzet E; Chiap P; Cohen N; Compagnon PA; Dewé W; Feinberg M; Lallier M; Laurentie M; Mercier N; Muzard G; Nivet C; Valat L
    J Pharm Biomed Anal; 2004 Nov; 36(3):579-86. PubMed ID: 15522533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. Examples of application.
    Hubert P; Nguyen-Huu JJ; Boulanger B; Chapuzet E; Cohen N; Compagnon PA; Dewé W; Feinberg M; Laurentie M; Mercier N; Muzard G; Valat L; Rozet E
    J Pharm Biomed Anal; 2008 Nov; 48(3):760-71. PubMed ID: 18768284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and economic HPLC performance qualification.
    Kaminski L; Degenhardt M; Ermer J; Feussner C; Höwer-Fritzen H; Link P; Renger B; Tegtmeier M; Wätzig H
    J Pharm Biomed Anal; 2010 Feb; 51(3):557-64. PubMed ID: 19801176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do placebo based validation standards mimic real batch products behaviour? Case studies.
    Bouabidi A; Talbi M; Bouklouze A; El Karbane M; Bourichi H; El Guezzar M; Ziemons E; Hubert P; Rozet E
    J Pharm Biomed Anal; 2011 Jun; 55(3):583-90. PubMed ID: 21377822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of various international guidelines for analytical method validation.
    Chandran S; Singh RS
    Pharmazie; 2007 Jan; 62(1):4-14. PubMed ID: 17294806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision from drug stability studies. Investigation of reliable repeatability and intermediate precision of HPLC assay procedures.
    Ermer J; Arth C; De Raeve P; Dill D; Friedel HD; Höwer-Fritzen H; Kleinschmidt G; Köller G; Köppel H; Kramer M; Maegerlein M; Schepers U; Wätzig H
    J Pharm Biomed Anal; 2005 Jul; 38(4):653-63. PubMed ID: 15967293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.
    Gnoth S; Jenzsch M; Simutis R; Lübbert A
    J Biotechnol; 2007 Oct; 132(2):180-6. PubMed ID: 17559961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical method transfer: new descriptive approach for acceptance criteria definition.
    de Fontenay G
    J Pharm Biomed Anal; 2008 Jan; 46(1):104-12. PubMed ID: 17961955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality by design compliant analytical method validation.
    Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
    Anal Chem; 2012 Jan; 84(1):106-12. PubMed ID: 22107128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifecycle management in pharmaceutical analysis: How to establish an efficient and relevant continued performance monitoring program.
    Ermer J; Aguiar D; Boden A; Ding B; Obeng D; Rose M; Vokrot J
    J Pharm Biomed Anal; 2020 Mar; 181():113051. PubMed ID: 31962246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control techniques for routine analysis with liquid chromatography in laboratories.
    Masson P
    J Chromatogr A; 2007 Jul; 1158(1-2):168-73. PubMed ID: 17418222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation in pharmaceutical analysis. Part I: an integrated approach.
    Ermer J
    J Pharm Biomed Anal; 2001 Mar; 24(5-6):755-67. PubMed ID: 11248468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The variability of AOAC methods of analysis as used in analytical pharmaceutical chemistry.
    Horwitz W
    J Assoc Off Anal Chem; 1977 Nov; 60(6):1355-63. PubMed ID: 924941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies.
    Geng D; Shankar G; Schantz A; Rajadhyaksha M; Davis H; Wagner C
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):364-75. PubMed ID: 15963677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and analysis of method equivalence studies.
    Borman PJ; Chatfield MJ; Damjanov I; Jackson P
    Anal Chem; 2009 Dec; 81(24):9849-57. PubMed ID: 19925005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalidation in pharmaceutical analysis. Part I. Fundamentals and critical discussion.
    Grdinić V; Vuković J
    J Pharm Biomed Anal; 2004 May; 35(3):489-512. PubMed ID: 15137975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.